Apellis Pharmaceuticals logo
Apellis Pharmaceuticals APLS
$ 30.76 10.85%

Quarterly report 2024-Q3
added 11-05-2024

report update icon

Apellis Pharmaceuticals Long Term Debt Current 2011-2024 | APLS

Annual Long Term Debt Current Apellis Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
6.44 M 5.62 M 4.12 M 3.68 M 2.61 M 1.67 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
6.44 M 1.67 M 4.02 M